Difference between revisions of "MEDICATION-LIGNOCAINE"

Revision as of 08:39, 30 December 2022

SUMMARY

1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
2. Indications: VF/pulseless or VT refractory to defibrillation.

SE
3. Nausea & vomiting.
4. CNS: slurred speech, drowsiness, seizures.
5. CVS: bradycardia, heart block, asystole.

DOSAGE
6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.

@@ Line 1: / Line 1: @@
-[[Summary Article|<h5>'''SUMMARY ARTICLE'''</h5>]]
+===== [[Summary Article|'''SUMMARY''']] =====
+. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
+<br/>2. Indications: VF/pulseless or VT refractory to defibrillation.
 <br/>
-<div>1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br/></div><div>SE</div><div>3. Nausea &amp; vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br/></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.  </div>
+<br/>SE
+<br/>3. Nausea & vomiting.
+<br/>4. CNS: slurred speech, drowsiness, seizures.
+<br/>5. CVS: bradycardia, heart block, asystole.
+<br/>
+<br/>DOSAGE
+<br/>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.
 [[Category:Medication]]
 [[Category:Advanced Life Support]]